• Policy
• External reference pricing reevaluations are nearly ready
• by Lee, Tak-Sun Jun 17, 2024 05:46am

• Policy
• CKD speeds up developing Duvie+Jardiance+metformin therapy
• by Lee, Hye-Kyung Jun 14, 2024 05:47am

• Policy
• Yuhan’s NSCLC new drug earns approval for clinical trial
• by Lee, Hye-Kyung Jun 14, 2024 05:47am

• Company
• Pfizer immediately reapplies to extend reimb for Lorviqua
• by Eo, Yun-Ho Jun 14, 2024 05:47am

• Product
• 92 patient groups implore doctors to stop the strike
• by Kang Hye-Kyung Jun 14, 2024 05:46am

• Company
• Industry concern rises over the spread of the medical strike
• by Kim, Jin-Gu Jun 14, 2024 05:46am

• Policy
• Drug pricing negotiations complete for Idelvion in KOR
• by Lee, Tak-Sun Jun 13, 2024 05:48am

• Company
• The first APDS drug 'Joenja' gets orphan drug status in KOR
• by Eo, Yun-Ho Jun 13, 2024 05:48am

• Policy
• "Chickenpox vaccine 'Sky Varicella Inj' is safe…"
• by Lee, Jeong-Hwan Jun 13, 2024 05:48am

• Policy
• CPAC ‘Scemblix’s orphan drug designation is valid’
• by Lee, Hye-Kyung Jun 13, 2024 05:48am